Bedside Rounds

Hyponatremia: workup and management

Serum sodium under 135 mEq/L. Severity of symptoms, not the number alone, decides urgency. Confirm hypotonicity, classify by volume status and urine studies, and limit the rate of correction to avoid osmotic demyelination.

Working diagnosis Adult · US guidelines Draft · awaiting physician review
Tailor to a patient with AI Bedside calculators Report an error

01Orient

What's new in the evidence

  • Symptomatic hyponatremia: rapid intermittent bolus 3% saline (100 mL over 10 min, up to 3 times) is preferred over continuous infusion (SALSA, 2021)
  • Large cohorts (2023) found osmotic demyelination rare and slow correction associated with higher mortality, but current guidance keeps the correction limits
  • Proactive desmopressin 'clamp' did not reduce overcorrection compared with reactive use in a 2024 RCT; it remains a specialist option
  • Overcorrection rescue: desmopressin 2–4 mcg IV/SC every 6–8 hours with D5W 3 mL/kg as needed

Differential diagnoses

  1. SIADH (drugs, malignancy, pulmonary or CNS disease, pain, nausea)
  2. Hypovolemia (GI losses, diuretics, especially thiazides)
  3. Heart failure, cirrhosis, nephrotic syndrome
  4. Primary polydipsia, beer potomania, tea-and-toast diet
  5. Adrenal insufficiency
  6. Hypothyroidism (severe)
  7. Pseudohyponatremia (lipids, paraproteins) or hyperglycemia

02Assess

Risk scores and decision tools

  • Serum osmolality, urine osmolality and urine sodium triad
  • ODS risk factors: Na ≤105, alcohol use disorder, malnutrition, hypokalemia, liver disease
  • Electrolyte-free water clearance to predict response to fluid restriction

Key history questions

  • Symptoms: headache, nausea, confusion, seizures, falls
  • Onset: known to be under 48 h (acute) or chronic/unknown
  • Drugs: thiazides, SSRIs, carbamazepine, oxcarbazepine, PPIs, MDMA
  • Fluid intake, alcohol, diet
  • Vomiting, diarrhea
  • Heart, liver or kidney disease

Examination findings

  • Volume status: orthostatics, JVP, mucous membranes, edema, ascites
  • Level of consciousness and focal signs
  • Signs of hypothyroidism or adrenal insufficiency

03Investigate

Initial investigations

  • Serum osmolality and glucose (corrected sodium)
  • Urine osmolality
  • Urine sodium
  • BMP, uric acid
  • TSH
  • Morning cortisol (or ACTH stimulation test if unclear)

Advanced investigations

  • Lipid panel and protein if serum osmolality normal
  • Chest imaging and head CT if SIADH without obvious cause
  • Urea or fractional uric acid excretion in difficult cases

04Treat

Immediate management

  • Severe symptoms (seizure, coma, vomiting with confusion): 3% saline 100 mL IV over 10 min, repeat up to 2 more times (peripheral line acceptable)
  • Aim for a 4–6 mEq/L rise in the first hours, which usually reverses severe symptoms
  • Check sodium after each bolus, then every 2–4 hours during active correction

First-line treatment

  • Correction limit: 8 mEq/L in 24 h for high ODS risk (alcohol use, malnutrition, hypokalemia, liver disease, Na ≤105); otherwise 10-12 mEq/L
  • Hypovolemic: isotonic saline; stop thiazides
  • SIADH: fluid restriction under about 1 L/day; treat the cause
  • Hypervolemic: fluid restriction, loop diuretics, treat HF or cirrhosis

Second-line treatment

  • SIADH: oral urea or tolvaptan if restriction fails (avoid tolvaptan in liver disease)
  • Over-correction: re-lower with D5W and desmopressin 2 mcg IV with nephrology input

Specialist referrals

  • Nephrology or endocrinology for severe or refractory cases
  • ICU for severe symptomatic hyponatremia needing hypertonic saline

05Disposition

Admission criteria

  • Moderate or severe symptoms
  • Sodium under 125 mEq/L in most cases
  • Needs IV therapy or close sodium monitoring

Safe discharge criteria

  • Chronic mild asymptomatic hyponatremia with clear cause
  • Stable sodium on repeat and outpatient labs arranged

Follow-up timing

  • Repeat sodium within 1 week of a medication or fluid change

Patient instructions

  • Follow the fluid restriction if given
  • Return with confusion, worsening headache or vomiting

Monitoring

  • Sodium every 2-4 h while correcting, then every 6-12 h
  • Urine output: a sudden large dilute diuresis signals risk of over-correction

Clinical pearls and pitfalls

  • Urine osmolality under 100 mOsm/kg suggests excess water or low solute intake
  • Urine sodium over 30 mEq/L on no diuretics points to SIADH or renal salt loss
  • Do not diagnose SIADH until hypothyroidism and adrenal insufficiency are excluded

RefGuidelines and landmark evidence

For education only. Typical adult starting points; confirm doses against renal function, allergies, interactions and your institution's protocols. Not a substitute for clinical judgment or senior review.